Report Detail

Medical Devices & Consumables Global and Japan Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2026

  • RnM4208262
  • |
  • 15 September, 2020
  • |
  • Global
  • |
  • 130 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Congestive Heart Failure (CHF) Treatment Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Congestive Heart Failure (CHF) Treatment Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Congestive Heart Failure (CHF) Treatment Devices market is segmented into
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

Segment by Application, the Congestive Heart Failure (CHF) Treatment Devices market is segmented into
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

Regional and Country-level Analysis
The Congestive Heart Failure (CHF) Treatment Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Congestive Heart Failure (CHF) Treatment Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Congestive Heart Failure (CHF) Treatment Devices Market Share Analysis
Congestive Heart Failure (CHF) Treatment Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Congestive Heart Failure (CHF) Treatment Devices business, the date to enter into the Congestive Heart Failure (CHF) Treatment Devices market, Congestive Heart Failure (CHF) Treatment Devices product introduction, recent developments, etc.
The major vendors covered:
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott


1 Study Coverage

  • 1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Congestive Heart Failure (CHF) Treatment Devices Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type
    • 1.4.2 Cardiac Resynchronization Therapy (CRT)
    • 1.4.3 Implantable Cardioverter Defibrillators (ICDs)
  • 1.5 Market by Application
    • 1.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application
    • 1.5.2 Left Ventricular Assist Device (LVAD)
    • 1.5.3 Right Ventricular Assist Device (RVAD)
    • 1.5.4 Biventricular Assist Device (BIVAD)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Estimates and Forecasts
    • 2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2015-2026
    • 2.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2015-2026
  • 2.2 Global Congestive Heart Failure (CHF) Treatment Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Congestive Heart Failure (CHF) Treatment Devices Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2021-2026)

3 Global Congestive Heart Failure (CHF) Treatment Devices Competitor Landscape by Players

  • 3.1 Global Top Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers
    • 3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue
    • 3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2019
    • 3.2.5 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers
  • 3.4 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution, Product Types
    • 3.4.1 Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
    • 3.4.3 Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type (2015-2020)
    • 4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2015-2020)
    • 4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020)
    • 4.1.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2021-2026)
    • 4.2.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application (2015-2020)
    • 5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2015-2020)
    • 5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2015-2020)
    • 5.1.3 Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
  • 5.2 Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales YoY Growth 2015-2026
    • 6.1.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2015-2026
  • 6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Sales (2015-2020)
    • 6.2.2 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Revenue (2015-2020)
  • 6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Type (2015-2020)
  • 6.4 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2021-2026)
  • 6.5 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
  • 6.6 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
  • 7.2 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
    • 7.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020)
    • 7.2.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
  • 8.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
    • 8.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country
    • 8.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
  • 10.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
    • 10.2.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
    • 10.2.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country
    • 11.2.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Abiomed
    • 12.1.1 Abiomed Corporation Information
    • 12.1.2 Abiomed Description and Business Overview
    • 12.1.3 Abiomed Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.1.5 Abiomed Recent Development
  • 12.2 Berlin Heart GmbH
    • 12.2.1 Berlin Heart GmbH Corporation Information
    • 12.2.2 Berlin Heart GmbH Description and Business Overview
    • 12.2.3 Berlin Heart GmbH Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.2.5 Berlin Heart GmbH Recent Development
  • 12.3 Biotronik SE & Co. KG
    • 12.3.1 Biotronik SE & Co. KG Corporation Information
    • 12.3.2 Biotronik SE & Co. KG Description and Business Overview
    • 12.3.3 Biotronik SE & Co. KG Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.3.5 Biotronik SE & Co. KG Recent Development
  • 12.4 Boston Scientific Corporation
    • 12.4.1 Boston Scientific Corporation Corporation Information
    • 12.4.2 Boston Scientific Corporation Description and Business Overview
    • 12.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.4.5 Boston Scientific Corporation Recent Development
  • 12.5 HeartWare International
    • 12.5.1 HeartWare International Corporation Information
    • 12.5.2 HeartWare International Description and Business Overview
    • 12.5.3 HeartWare International Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.5.5 HeartWare International Recent Development
  • 12.6 Jarvik Heart
    • 12.6.1 Jarvik Heart Corporation Information
    • 12.6.2 Jarvik Heart Description and Business Overview
    • 12.6.3 Jarvik Heart Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.6.5 Jarvik Heart Recent Development
  • 12.7 LivaNova PLC
    • 12.7.1 LivaNova PLC Corporation Information
    • 12.7.2 LivaNova PLC Description and Business Overview
    • 12.7.3 LivaNova PLC Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.7.5 LivaNova PLC Recent Development
  • 12.8 Medtronic
    • 12.8.1 Medtronic Corporation Information
    • 12.8.2 Medtronic Description and Business Overview
    • 12.8.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.8.5 Medtronic Recent Development
  • 12.9 ReliantHeart
    • 12.9.1 ReliantHeart Corporation Information
    • 12.9.2 ReliantHeart Description and Business Overview
    • 12.9.3 ReliantHeart Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.9.5 ReliantHeart Recent Development
  • 12.10 Abbott
    • 12.10.1 Abbott Corporation Information
    • 12.10.2 Abbott Description and Business Overview
    • 12.10.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.10.5 Abbott Recent Development
  • 12.11 Abiomed
    • 12.11.1 Abiomed Corporation Information
    • 12.11.2 Abiomed Description and Business Overview
    • 12.11.3 Abiomed Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered
    • 12.11.5 Abiomed Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Congestive Heart Failure (CHF) Treatment Devices Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Congestive Heart Failure (CHF) Treatment Devices Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Congestive Heart Failure (CHF) Treatment Devices. Industry analysis & Market Report on Congestive Heart Failure (CHF) Treatment Devices is a syndicated market report, published as Global and Japan Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Congestive Heart Failure (CHF) Treatment Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,116.10
    4,674.15
    6,232.20
    3,638.70
    5,458.05
    7,277.40
    606,645.00
    909,967.50
    1,213,290.00
    324,987.00
    487,480.50
    649,974.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report